Gujarat Alkalies Downgraded by CareEdge to CARE AA-; Stable

CHEMICALS
Whalesbook Corporate News Logo
AuthorRiya Kapoor|Published at:
Gujarat Alkalies Downgraded by CareEdge to CARE AA-; Stable

CareEdge Ratings downgraded Gujarat Alkalies and Chemicals' long-term bank facilities to CARE AA- from CARE AA. This reflects slower-than-expected financial performance due to market pressures and operational challenges.

Gujarat Alkalies Sees Rating Downgrade Amidst Market Pressures

Gujarat Alkalies and Chemicals Limited's long-term bank facilities have been downgraded by CareEdge Ratings to CARE AA- (Stable) from CARE AA. The rating agency cited slower-than-anticipated improvement in the company's consolidated financial performance over the last two fiscal years as the primary reason.

Reader Takeaway: Persistent margin pressure; future performance hinges on capacity ramp-up and capex execution.

What just happened

CareEdge Ratings has revised the rating for Gujarat Alkalies and Chemicals Limited (GACL)'s long-term bank facilities from CARE AA to CARE AA- with a 'Stable' outlook. The rating for short-term bank facilities and commercial paper remains reaffirmed at CARE A1+.

Why this matters

The downgrade signals potential increased borrowing costs and reflects concerns about the company's near-term financial health and operational recovery. Investors will watch how GACL manages its debt and operational challenges.

The backstory

The rating revision is driven by a combination of external market pressures and internal operational factors. Moderate caustic soda prices and negative realisations for chlorine have impacted margins. Additionally, the recovery in operating performance has been slower than anticipated, due to weaker off-take of downstream products and a slower ramp-up of new capacities.

What changes now

The company's long-term borrowing facilities are now rated CARE AA- instead of CARE AA. The 'Stable' outlook suggests the agency expects GACL to maintain its market position and improve its financial risk profile over the medium term.

Risks to watch

Profitability remains susceptible to energy price volatility. GACL also has significant capital expenditure plans of ₹1,300-1,400 crore over the next three years, which are largely debt-funded. Managing this expansion without adversely impacting the balance sheet is crucial.

Peer comparison

GACL operates in the chlor-alkali industry, which is known for its cyclicality. The company benefits from integrated operations and a diversified user base, which offers some resilience.

Context metrics (time-bound)

For FY26 (Un-audited Actuals), Total Operating Income was ₹5,091 crore, PBILDT was ₹546 crore, and PAT was ₹2 crore. In Q1FY27 (Un-audited Actuals), Total Operating Income stood at ₹1,245 crore, and PBILDT was ₹222 crore. PAT for Q1FY27 was not available (NA).

What to track next

Investors should monitor GACL's progress in effectively ramping up its recently commissioned capacities, improving chlorine realisations, and managing its debt-funded capital expenditure. The company's ability to navigate energy cost volatility will also be a key factor.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.